ey0020.6-5 | Important for Clinical Practice | ESPEYB20
M Engelen
, WJC van Ballegoij
, EJ Mallack
, KP Van Haren
, W Kohler
, E Salsano
, ASP van Trotsenburg
, F Mochel
, C Sevin
, MO Regelmann
, NA Tritos
, A Halper
, RH Lachmann
, J Davison
, GV Raymond
, TC Lund
, PJ Orchard
, JS Kuehl
, CA Lindemans
, P Caruso
, BR Turk
, AB Moser
, FM Vaz
, S Ferdinandusse
, S Kemp
, A Fatemi
, FS Eichler
, IC Huffnagel
Brief summary: This paper describes consensus expert recommendations for the diagnosis and management of patients with Adrenoleukodystrophy.Adrenoleukodystrophy (ALD), a progressive metabolic disorder with variable and unpredictable clinical course, is caused by pathogenic variants in ABCD1 gene leading to deficient β-oxidation of saturated very-long-chain fatty acids (VLCFAs) (1, 2). Patients are asymptomatic at birth but ...